National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
April 17, 2012 • Volume 9 / Number 8

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document


Free Telephone Workshop Series for Cancer Survivors Begins April 24

Richard Dickens, Dr. David Spiegel, Dr. Lorenzo Cohen Richard Dickens, Dr. David Spiegel, and Dr. Lorenzo Cohen

The tenth annual Cancer Survivorship Series "Living With, Through, and Beyond Cancer" will hold the first of four workshops on April 24, from 1:30 to 2:30 p.m. ET. This free series offers cancer survivors, their families, friends, and health care professionals practical information to help them cope with concerns and issues that arise after treatment ends.

Part I of the series is titled "Using Mind/Body Techniques to Cope with the Stress of Survivorship." Workshop speakers include Richard Dickens of CancerCare, Dr. Lorenzo Cohen of the University of Texas MD Anderson Cancer Center, and Dr. David Spiegel of Stanford University School of Medicine.

Participants can listen online or by telephone. To register, visit the CancerCare website.

The remaining three workshops will be held from 1:30 to 2:30 p.m. ET on the following dates:

These workshops are presented by CancerCare, in collaboration with NCI, LIVESTRONG, the American Cancer Society, the Intercultural Cancer Council, Living Beyond Breast Cancer, and the National Coalition for Cancer Survivorship.

Public Comment Sought on Draft Statement on Ovarian Cancer Screening

The U.S. Preventive Services Task Force (USPSTF) issued a draft statement reaffirming its recommendation against routine screening for ovarian cancer in women who are at average risk of the disease. The draft Reaffirmation Recommendation Statement is available for comment until May 8 at 5:00 p.m. ET.

Based on an evidence review published April 10, the USPSTF concluded that routine screening with transvaginal ultrasound and testing for the serum tumor marker CA-125 does not help to reduce deaths from ovarian cancer. "There is at least moderate certainty that the harms of screening for ovarian cancer outweigh the benefits," the draft states.

Instructions on how to submit comments are available online.

See also: "Ovarian Cancer Screening Method Fails to Reduce Deaths from the Disease"

Apply to Visiting Scholars Program at Frederick National Laboratory by May 11

The Frederick National Laboratory for Cancer Research, until recently known as NCI-Frederick, is accepting applications to its new Visiting Scholars Program. The program is a unique opportunity for researchers to work on important cancer and AIDS projects with teams of scientists at the only national laboratory in the United States devoted exclusively to biomedical research.

In 2012, visiting scholars will have the opportunity to work on challenges related to affinity reagents, proteomics, advanced preclinical research, and virus genomics. Applicants may also propose their own research focus that supports the Frederick National Laboratory's mission, research programs, and capabilities.

Program coordinators invite early career and established investigators within or outside the cancer research community to submit an Expression of Interest form by May 11. More information about eligibility and how to apply is available online

Applications for Oncology Fellowships Due May 31

IOTF tile

The Interagency Oncology Task Force (IOTF), a joint initiative between NCI and the Food and Drug Administration (FDA), recently announced fellowship training opportunities for Ph.D.s, M.D.s, and M.D./Ph.D.s (or their equivalents).  

The IOTF Joint Fellowship Program trains scientists in cancer research and research-related regulatory review to develop skills needed to bridge the two distinct processes. Fellows will learn to build awareness of regulatory requirements into the early stages of medical product development and will devise strategies to improve planning throughout the research and regulatory review phases.

"We believe that physicians and scientists who are highly trained in the regulatory process, and who also have an understanding of the inner workings of NCI and the FDA, will be able to facilitate and speed the development and approval process for drugs, especially for chemotherapy," said Dr. Jonathan Wiest, director of NCI's Center for Cancer Training.

Fellowships are available in Oncology Product Research/Review. Applications are due May 31 for fellowships that begin in September 2012. More information about the fellowships and eligibility requirements is available online .

NCI Requests Targets for Monoclonal Antibody Production and Characterization

The Antibody Characterization Program in NCI's Office of Cancer Clinical Proteomics Research provides researchers with reagents and other critical resources that support protein/peptide measurements and analysis. In an effort to provide well-characterized monoclonal antibodies to the scientific community, the program requests cancer-related protein targets for affinity production and distribution. Submissions will be accepted through July 9.

Submissions will be reviewed and considered for merit based on their justification and contribution to existing NCI-funded projects. Priority will be given to projects that apply the antibodies to proteomics research.

Successful applicants can expect to be notified on or before August 30. All materials (such as proteins/peptides) must be ready and available when a target is submitted. For more information and the application form, please go to NCI's Antibodies Data Portal.

Please address questions to Dr. Tara Hiltke at or 301-451-8511.

< Previous Section